BDSX
BDSX
NASDAQ · Health Care

Biodesix Inc

$30.42
+1.32 (+4.54%)
As of Sep 28, 10:24 PM ET ·
Financial Highlights (FY 2026)
Revenue
123.66M
Net Income
-49,275,832
Gross Margin
81.1%
Profit Margin
-39.9%
Rev Growth
+32.3%
D/E Ratio
1.75
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 81.1% 81.1% 33.3% 33.3%
Operating Margin -31.5% -28.3% 8.0% 6.7%
Profit Margin -39.9% -37.9% 8.0% 7.4%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 123.66M 93.46M 49.37M 47.38M
Gross Profit 100.30M 75.81M 16.44M 15.77M
Operating Income -38,953,282 -26,496,828 3.95M 3.19M
Net Income -49,275,832 -33,518,440 3.95M 3.51M
Gross Margin 81.1% 81.1% 33.3% 33.3%
Operating Margin -31.5% -28.3% 8.0% 6.7%
Profit Margin -39.9% -37.9% 8.0% 7.4%
Rev Growth +32.3% +32.3% +11.0% +13.7%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 97.59M 97.59M 13.54M 13.68M
Total Equity 55.93M 55.93M 42.24M 42.97M
D/E Ratio 1.75 1.75 0.32 0.32
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -31,700,834 -22,761,539 4.35M 3.95M
Free Cash Flow — — 1.71M 2.32M